Report #2862520

Received Oct 1, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 0.7 yrs
State: CT
Recovered: Unknown
Vaccinated: Sep 15, 2025
Onset: Sep 15, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RVX	ROTAVIRUS (NO BRAND NAME)	UNKNOWN MANUFACTURER	3	7E9Y2	—

Symptoms (2)

Extra dose administeredProduct administered to patient of inappropriate age

Symptom narrative

an 8-month patient had received a dose of Rotarix; 3rd dose administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 8-month-old female patient who received Rotavirus vaccine (batch number 7E9Y2, expiry date 30-MAY-2026) for prophylaxis. Previously administered products included Rotarix (received 2 doses on an unknown date). On 15-SEP-2025, the patient received the 3rd dose of Rotavirus vaccine. On 15-SEP-2025, an unknown time after receiving Rotavirus vaccine, the patient experienced inappropriate age at vaccine administration (Verbatim: an 8-month patient had received a dose of Rotarix) and extra dose administered (Verbatim: 3rd dose administered). The outcome of the inappropriate age at vaccine administration and extra dose administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.